05478853 is referenced by 16 patents and cites 2 patents.

The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes.

A compound disclosed is: 5-{4-[2-(2-methoxy-5-chlorobenzamido)ethyl]benzyl}thiazolidine-2,4-dione.

Title
Thazolidinedione compounds
Application Number
133898
Publication Number
5478853
Application Date
January 20, 1995
Publication Date
December 26, 1995
Inventor
Joseph Espinal
Paris
FR
Jacques Duhault
Croissy Sur Seine
FR
Yves Charton
Sceaux
FR
Gilbert Regnier
Chatenay Malabry
FR
Agent
Gordon W Hueschen
Assignee
Adir et Compagnie
FR
IPC
A61K 31/425
C07D 277/34
View Original Source